Incruse Ellipta
Drug Price Transparency organizes records from CMS data API into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
- Title
- Incruse Ellipta
- Record Date
- 01/01/2024
- Vuga Group
- Umeclidinium Bromide
- Change Status
- increased
- Recency Days
- 972.23
- Public Significance Score
- 11.358